Conflicts of interest are on the table next Thursday at a meeting of the governing board of California’s $12 billion stem cell research program, but not the ones involving members of the board itself.
Next week’s session involves “advisory task forces,” some of which are likely to come into play in connection with the agency’s sweeping, new responsibili…
